PURMINDS Trademark

Trademark Overview

On Wednesday, November 3, 2021, a trademark application was filed for PURMINDS with the United States Patent and Trademark Office. The USPTO has given the PURMINDS trademark a serial number of 97106924. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Wednesday, September 17, 2025. This trademark is owned by PurMinds Biopharma Inc.. The PURMINDS trademark is filed in the Pharmaceutical Products, Advertising and Business and Retail Services categories with the following description:

Prescription pharmaceutical preparations for the prevention and treatment of neurological disorders and neurodegenerative diseases and Alzheimer's disease; Pharmaceuticals, namely, psychotropics, psychoactive compounds, and non-psychoactive compounds and molecules for the prevention and treatment of neurological disorders, neurodegenerative diseases, and Alzheimer's disease

Advertising and marketing of psychoactive compounds derived from natural sources and chemical synthesis of others; Wholesale distributorships, on-line wholesale and retail store services featuring psychoactive compounds derived from natural sources and chemical synthesis; analysis of neuroinformatic data and algorithms generated through the drug discovery process for business purposes
purminds

General Information

Serial Number97106924
Word MarkPURMINDS
Filing DateWednesday, November 3, 2021
Status730 - FIRST EXTENSION - GRANTED
Status DateWednesday, September 17, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 6, 2024

Trademark Statements

Goods and ServicesPrescription pharmaceutical preparations for the prevention and treatment of neurological disorders and neurodegenerative diseases and Alzheimer's disease; Pharmaceuticals, namely, psychotropics, psychoactive compounds, and non-psychoactive compounds and molecules for the prevention and treatment of neurological disorders, neurodegenerative diseases, and Alzheimer's disease
Pseudo MarkPURE MINDS
Goods and ServicesAdvertising and marketing of psychoactive compounds derived from natural sources and chemical synthesis of others; Wholesale distributorships, on-line wholesale and retail store services featuring psychoactive compounds derived from natural sources and chemical synthesis; analysis of neuroinformatic data and algorithms generated through the drug discovery process for business purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 27, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, October 27, 2023
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePurMinds Biopharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBolton, Ontario L7E1J9
CA
Party NamePurMinds Biopharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBolton, Ontario L7E1J9
CA

Trademark Events

Event DateEvent Description
Saturday, November 6, 2021NEW APPLICATION ENTERED
Saturday, November 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 10, 2023ASSIGNED TO EXAMINER
Wednesday, April 26, 2023NON-FINAL ACTION WRITTEN
Wednesday, April 26, 2023NON-FINAL ACTION E-MAILED
Wednesday, April 26, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 25, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, July 25, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, October 26, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 27, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 7, 2023ASSIGNED TO EXAMINER
Wednesday, June 5, 2024EXPARTE APPEAL RECEIVED AT TTAB
Tuesday, December 5, 2023FINAL REFUSAL WRITTEN
Tuesday, December 5, 2023FINAL REFUSAL E-MAILED
Tuesday, December 5, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, February 22, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, February 22, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, June 5, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 5, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 5, 2024EX PARTE APPEAL-INSTITUTED
Wednesday, June 5, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, June 5, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, June 5, 2024TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, June 5, 2024DIVISIONAL REQUEST RECEIVED
Thursday, June 6, 2024DIVISIONAL PROCESSING COMPLETE
Thursday, June 6, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 1, 2024EXPARTE APPEAL TERMINATED
Monday, July 1, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 6, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 1, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 26, 2025SOU EXTENSION 1 FILED
Wednesday, March 26, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, August 6, 2024PUBLISHED FOR OPPOSITION
Wednesday, September 17, 2025SOU EXTENSION 1 GRANTED
Thursday, September 18, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 1, 2025SOU TEAS EXTENSION RECEIVED

Related Keywords

purminds compounds psychoactive derived from sources wholesale synthesis chemical disease natural